UNSPSC 51101932: Menoctone

This classification denotes an antimalarial agent with the molecular formula C24H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QP1A5BD6K9, chemically known as 1,4-naphthoquinone, 2-(8-cyclohexyloctyl)-3-hydroxy- (8ci) but generally known as menoctone, which bears US NIH Compound Identifier 26738. European Medicines Agency schedules Menoctone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08741MIG.

UNSPSC 51101932 Menoctone, a Commodity code, describes pharmaceutical products including naloxone, generic multi-source pharmaceuticals, and over-the-counter products that state and local governments procure for emergency medical response, community health initiatives, and employee health benefit programs. The code spans both direct pharmaceutical procurement (naloxone and opioid-reversal agents) and broader medication supply arrangements through wholesale distribution networks and cooperative purchasing vehicles. State and local issuing bodies soliciting under this code include county health departments, city fire and rescue divisions, state health and human services agencies, and multistate cooperative purchasing alliances coordinating pharmaceutical contracts across participating state and local members.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to its Community Health Building, with a two-year initial term and one-year renewal option. The City of Tampa issued IFB 26-P-00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a one-year award period plus two optional one-year renewals; this procurement was designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities, including Oregon, through authorized wholesalers AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., with proposals due March 26, 2026 and awards effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities for a Therapeutic Pharmacy Initiative program, reflecting early-stage procurement planning rather than a formal competitive solicitation.